Matthew Vincent Dolan, EVP Strategy and Corporate at DEXCOM INC (DXCM), sold 13,420 shares at $134.41 ($1.8M) on 2024-03-12, disclosed to the SEC on 2024-03-14.
Open-market sale of $1.8M DXCM by EVP Strategy and Corporate. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $134.41 | 6,710 | $902K | 50.0% |
| 2 | $134.41 | 6,710 | $902K | 50.0% |
| Total | $134.41 avg | 13,420 | $1.8M | 100% |
| Filing → |
| DXCM | SELL | 2024-04-16 | $548K | — | Filing → |
| DXCM | SELL | 2024-03-19 | $1.1M | — | Filing → |
| DXCM | SELL | 2023-09-01 | $6K | — | Filing → |